John B. Guerard, Jr.
Director of Quantitative Research
McKinley Capital Management, LLC.
John B. Guerard, Jr., PhD, is the Director of Quantitative Research at McKinley Capital Management, LLC. Dr. Guerard focuses on maintaining and enhancing the firm’s quantitative capabilities and investment models. Before joining McKinley Capital in 2005, Dr. Guerard held a number of senior-level positions, including Vice President at Daiwa Securities Trust Co., where he co-managed the Japan Equity Fund with Nobel Prize winner Dr. Harry Markowitz. He is the author of numerous books and articles, including An Introduction to Financial Forecasting in Investment Analysis and Quantitative Corporate Finance. He is also a former faculty member at the Rutgers University Graduate School of Management and at Lehigh University. Dr. Guerard earned an AB degree in Economics from Duke University, an MA degree in Economics from the University of Virginia, an MSIM in Finance from the Georgia Institute of Technology, and a PhD in Finance from the University of Texas at Austin.
By This Author
Portfolio and Investment Analysis with SAS®: Financial Modeling Techniques for Optimization
By John B. Guerard Jr., Ganlin Xu, and Ziwei Wang
Portfolio and Investment Analysis with SAS®: Financial Modeling Techniques for Optimization is designed to show readers how use SAS to choose a statistically significant stock selection model, create Mean-Variance efficient portfolios, and be aggressive in investing to maximize the Geometric Mean. Based on the pioneering portfolio selection techniques of Harry Markowitz and others, this book shows how to maximizing the Geometric Mean maximizes the utility of final wealth to achieve the greatest level of terminal wealth in the shortest time possible.
*Our books are also available in print and e-book formats
from your local bookstore or favorite online bookseller.
Featured Authors
-
Ron Klimberg, PhD, is a professor at the Haub School of Business at Saint Joseph's University in Philadelphia, PA.
-
Terisa Roberts is a director and Global Solution lead for Risk Modeling and Decisioning at SAS. She has extensive experience in quantitative risk management, regulatory compliance, and model governance and validation. She has worked in financial services, telecommunications, government, energy, and retail sectors.
-
Todd Case has been working in the pharmaceutical industry as a statistical programmer for over 20 years. He completed his MS in Epidemiology from Columbia University and has worked at Forest Laboratories (now Allergan), Genentech, Bristol-Myers Squibb, and Biogen. He currently works at Vertex Pharmaceuticals.
-
Robert N. Rodriguez retired from SAS in 2018 after serving as a senior director in research and development. Bob received a PhD in statistics from the University of North Carolina at Chapel Hill and was a research statistician at General Motors Research Laboratories before joining SAS.